Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of sodium pentaborate pentahydrate in people with overweight and obesity
IRCT20220614055167N3Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2023
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sodium pentaborate pentahydrate in Overweight and obesity, sponsored by Tabriz University of Medical Sciences. Started Mar 2023; status: completed.
02
Drugs
sodium pentaborate pentahydrate
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on IRCT20220614055167N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220614055167N3.